Home › Stocks › JNJ vs PFE
JNJ
Johnson & Johnson
$228.92
vs
PFE
Pfizer Inc.
$25.33

Head-to-Head Comparison

MetricJNJPFE
Market Cap$551.1B$144.4B
P/E Ratio16.010.0
Div YieldN/AN/A
SectorHealthcareHealthcare
Beta0.260.30
RevenueN/AN/A
Net IncomeN/AN/A
EPSN/AN/A

AI Comparison Brief

AI Generated
Verdict
Johnson & Johnson (JNJ) is the better investment at this time due to its significantly larger market cap of $551.06B compared to Pfizer Inc. (PFE) at $144.37B, indicating a more stable and established business. JNJ's lower beta of 0.263 suggests reduced volatility, making it a safer choice in a turbulent market. While both companies currently lack P/E and EPS data, JNJ's strong market position in the healthcare sector and diversified product lines provide a superior growth trajectory and risk/reward profile.
Key Differences
  • Market Position: JNJ boasts a dominant market cap of $551.06B, reflecting its extensive portfolio and market presence, while PFE's $144.37B indicates a smaller footprint in the sector.
  • Volatility: With a beta of 0.263, JNJ presents a lower risk compared to PFE's 0.305, making it a more stable investment option for risk-averse investors.
  • Growth Potential: JNJ's diversified operations across various healthcare segments may provide more consistent growth opportunities versus PFE's reliance on specific drug pipelines.
  • Dividend Policy: Both companies currently have unspecified dividend yields, but JNJ's established history of dividends suggests potential income stability, whereas PFE's dividend strategy remains less clear.
Bottom Line
Investors seeking stability and long-term growth should favor Johnson & Johnson, while those willing to take on slightly more risk for potentially higher volatility could consider Pfizer. JNJ represents a more secure investment in the healthcare sector.
This comparison is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Analysis generated 2026-06-02

Price Chart — JNJ vs PFE

Loading chart...
→ Johnson & Johnson (JNJ) Full Analysis → Pfizer Inc. (PFE) Full Analysis ← Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms